Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Neurosyphilis Companies

Neurosyphilis is a severe form of syphilis that affects the central nervous system. It occurs when the bacterium Treponema pallidum invades the nervous system, leading to various neurological complications. The treatment of neurosyphilis typically involves antibiotics, such as penicillin, administered intravenously. While there may not be specific companies exclusively focused on neurosyphilis, pharmaceutical companies that develop antibiotics and medications for infectious diseases may have products relevant to its treatment.

Neurosyphilis Key Companies

Latest Neurosyphilis Companies Update

Positive Phase 2b results for AL101 (Alopexx Pharmaceuticals) December 2023 breakthrough demonstrated AL101's potential as a safe and effective treatment for neurosyphilis, a previously unmet medical need. Phase 3 trials are expected to begin soon.

Focus on repurposing existing drugs Companies are exploring the efficacy of existing medications like minocycline and ceftriaxone for treating neurosyphilis, potentially offering faster treatment options while awaiting new drug approvals.

Luminex Corporation: November 2023, Luminex launched a multiplex assay called Verیده (Veride) for simultaneous detection of syphilis and other sexually transmitted infections, including HIV-1 and -2. This could potentially facilitate faster and more comprehensive diagnosis of neurosyphilis.

Mologic company is developing a rapid point-of-care test for syphilis, including neurosyphilis. While still in the early stages of development, such a test could significantly improve access to timely diagnosis in resource-limited settings.

List of Neurosyphilis Key Companies in the Market

Abbott (US)

Bayer AG (Germany)

Eli Lilly and Company (US)

GlaxoSmithKline plc. (UK)

Novartis AG (Switzerland)

Pfizer Inc. (US)

Sanofi (France)

Neurosyphilis Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.